Form 4: Inotiv Director Sells Shares Under 10b5-1 Plan

Inotiv Director R. Matthew Neff sold 2,000 shares of common stock at a weighted average price of $1.909 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• R. Matthew Neff, a Director of Inotiv, Inc. (NOTV), sold 2,000 shares of the company's common stock.
• The transaction occurred on August 1, 2025.
• The shares were sold at a weighted average price of $1.909 per share, with individual sale prices ranging from $1.885 to $1.930.
• Following this transaction, Mr. Neff beneficially owns 149,102 shares of Inotiv common stock.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted by Mr. Neff on February 13, 2025.

Sentiment

Score: 5

Explanation: A neutral score. While insider selling can be perceived negatively, the execution under a 10b5-1 plan mitigates immediate concerns about new negative information, suggesting a planned liquidity event rather than a loss of confidence.

Positives

• The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned transaction rather than an immediate reaction to new, undisclosed information.

Negatives

• A director selling shares, even under a 10b5-1 plan, can be perceived negatively by the market as it reduces insider ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2025.
• The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Industry Context

Insider transactions, such as those reported on Form 4, are common in the market. Sales under Rule 10b5-1 plans are pre-scheduled and designed to avoid accusations of trading on material non-public information, distinguishing them from opportunistic sales.

Stakeholder Impact

• Shareholders may interpret the director's sale as a slight negative signal, though the 10b5-1 plan context reduces this impact. The reduction in insider ownership is minimal relative to total shares outstanding.

Next Steps

• The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Key Dates

Recommendation

The filing details a routine insider sale executed under a pre-arranged 10b5-1 plan, which typically does not signal new material information about the company's prospects. While insider selling can be a minor negative, this specific transaction is small (2,000 shares) relative to the director's remaining holdings (149,102 shares) and the company's overall market capitalization. It does not provide sufficient new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Inotiv, NOTV, Insider Trading, Form 4, Stock Sale, Director, R. Matthew Neff, 10b5-1 Plan, Equity Transaction